Profil bibliographique

Hendrikus J. Dubbink

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

212Publications signalées

8031Citations signalées

3Affiliations récentes

Institutions déclarées

Erasmus MC Erasmus MC Cancer Institute Erasmus University Rotterdam

Domaines associés

Glioma Diagnosis and TreatmentCancer Genomics and DiagnosticsRadiomics and Machine Learning in Medical ImagingBrain Metastases and TreatmentLung Cancer Treatments and Mutations

Publications récentes

Accès ouvert 2025 articleOpenAlex

Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial

Martin J van den Bent, S A Ghisai, Wolfgang Wick, M. Sanson et autres

13 citationsThe Lancet Oncology

Accès ouvert 2025 articleOpenAlex

Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study

Tijmen J.W.T. van der Wel, Sophie M. Ernst, M. Jebbink, Daan van den Broek et autres

2 citationsLung Cancer

Accès ouvert 2025 articleOpenAlex

Analytical Validation of a Pan-Cancer Next-Generation Sequencing Assay for In-House Liquid Biopsy Testing

Gaëlle Lescuyer, Alexandre Harlé, Pantelis Constantoulakis, Nicole Pfarr et autres

3 citationsJournal of Molecular Diagnostics

Accès ouvert 2025 articleOpenAlex

Yield of next-generation sequencing in diagnostic work up of suspicious biliary strictures

Tina L.N. Meijering, David M. de Jong, Swip Draijer, Hendrikus J. Dubbink et autres

0 citationsEndoscopy International Open

Accès ouvert 2025 articleOpenAlex

Circulating tumour cells & circulating tumour DNA in patients with resectable colorectal liver metastases (MIRACLE): a prospective, observational biomarker study

Lissa Wullaert, Maurice P.H.M. Jansen, Jaco Kraan, Yannick Meyer et autres

10 citationsEClinicalMedicine

Accès ouvert 2025 reviewOpenAlex

Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials

Sophie M. Ernst, Mihaela Aldea, Jan H. von der Thüsen, Adrianus J. de Langen et autres

11 citationsNature Reviews Clinical Oncology

Accès ouvert 2025 articleOpenAlex

Analysis of comprehensive genomic profiling of solid tumors with a novel assay for broad analysis in clinical diagnostics

Guy Froyen, Pieter‐Jan Volders, Ellen Geerdens, Severine Berden et autres

3 citationsMolecular Oncology

Accès ouvert 2025 preprintOpenAlex

The Clinical Benefit of Routine Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer for the Detection of Prognostic Co-Mutations – a Multicenter Next Generation Sequencing Study

Shaylin Aman Soekhoe, Anne‐Marie C. Dingemans, Folkert J. van Kemenade, Remigio W. Rouse et autres

0 citationsSSRN Electronic Journal

2024 peer-reviewOpenAlex

Author response for "Analysis of comprehensive genomic profiling of solid tumors with a novel assay for broad analysis in clinical diagnostics"

Guy Froyen, Pieter‐Jan Volders, Ellen Geerdens, Severine Berden et autres

0 citations

Accès ouvert 2024 articleOpenAlex

Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy

Veronique de Jager, P. Plomp, Marthe S. Paats, Sjoerd van Helvert et autres

6 citationsESMO Open

Accès ouvert 2024 preprintOpenAlex

Analytical Validation of a Pan-Cancer NGS Assay for In-House Liquid Biopsy Testing: An International Multicenter Study

Gaëlle Lescuyer, Alexandre Harlé, Hamsa L.S. Kumar, Pantelis Constantoulakis et autres

2 citationsmedRxiv

Accès ouvert 2024 otherOpenAlex

Data from Differences in the Prognostic Role of Age, Extent of Resection, and Tumor Grade between Astrocytoma IDHmt and Oligodendroglioma: A Single-Center Cohort Study

Thijs van der Vaart, Maarten M.J. Wijnenga, Karin A. van Garderen, Hendrikus J. Dubbink et autres

0 citations

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.